StockData
Pharming Group N.V. logo

Pharming Group N.V. (PHAR) stock

PHARNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 2, 2026Score 8/30
$12.48+0.42 (+3.51%)

Close on Nov 18, 2026Market cap $875.92MP/E 312.1Yield –

Pharming gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

For fiscal 2025 it was $330.63M, up 26.3% from the year before. The highest annual figure on record is $330.63M in fiscal 2025.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$330.63M+26.3%
FY2024Dec 31, 2024$261.80M+18.9%
FY2023Dec 31, 2023$220.10M+17.0%
FY2022Dec 31, 2022$188.06M+5.8%
FY2021Dec 31, 2021$177.73M-5.8%
FY2020Dec 31, 2020$188.64M+14.0%
FY2019Dec 31, 2019$165.46M–

More Pharming figures

See a number that looks wrong?